A case of spinal seeding of craniopharyngioma mimicking as pituitary abscess

The human brain is encased in a protective fluid that circulates through the central nervous system, acting as both a cushion and a transport network. When a tumor forms near the pituitary gland, a small but vital structure at the base of the brain, it usually stays put. However, in rare instances, cells from a tumor can break loose and travel through this fluid to other parts of the spine. Distinguishing between a tumor that has spread and a severe infection is one of the most difficult challenges in neurology, because both can cause fever, headaches, and swelling that look nearly identical on medical scans. When doctors see these signs, they often treat for infection first, assuming a tumor is unlikely to behave this way. Understanding how these rare tumors move and how to identify them without immediate surgery is crucial, as it changes the entire path of treatment from fighting bacteria to targeting specific genetic errors within the cells.

A team of researchers at Huashan Hospital in China recently documented a striking case that illustrates just how deceptive these conditions can be. They followed a 59-year-old woman who arrived at the hospital with a two-year history of persistent headaches and recurring fevers that reached nearly 39 degrees Celsius. For a long time, the medical team believed she was suffering from a pituitary abscess, a pocket of pus caused by a bacterial or fungal infection. This diagnosis seemed logical because her spinal fluid showed high levels of white blood cells and low sugar, classic signs of infection, and her brain scans revealed a ring of bright enhancement that often indicates an abscess. Despite receiving powerful antibiotics and antiviral medications, and even undergoing surgery to drain what appeared to be pus from the base of her brain, her symptoms did not fully resolve. She continued to run fevers, and over time, she began to develop new problems, including vision loss, memory issues, and an unsteady gait.

The turning point came when the medical team decided to look closer at the fluid circulating around her spine. In May 2023, a detailed examination of her spinal fluid revealed something unexpected: instead of just bacteria or inflammatory cells, the fluid was filled with squamous epithelial cells. These are flat, scale-like cells that do not belong in the spinal fluid under normal circumstances. Further testing uncovered a specific genetic change known as the BRAF V600E mutation within these cells. This genetic marker is a hallmark of a specific type of brain tumor called papillary craniopharyngioma. The presence of these cells in the spinal fluid, combined with the genetic evidence, led the doctors to a startling conclusion. The woman did not have an infection; she had a rare tumor that had spread from the base of her brain down into her spinal canal, mimicking an abscess so perfectly that it had fooled doctors for two years.

Once the true nature of the condition was identified, the treatment strategy shifted dramatically. The patient was taken off antibiotics and started on a targeted therapy designed to block the specific genetic mutation driving the tumor. She received a combination of two drugs, dabrafenib and trametinib, which work by shutting down the faulty signals that tell the cancer cells to grow. The response was rapid and significant. Follow-up scans showed that the lesions in her brain and spine were shrinking, and the number of tumor cells in her spinal fluid dropped sharply. A subsequent surgery confirmed that the mass in her brain was indeed a papillary craniopharyngioma, and the spinal lesions were responding well to the medication. The patient eventually achieved a state where her spinal fluid showed tumor cells predominantly undergoing apoptosis and degradation, with signs of gradual metabolic clearance, a result described as cytological remission.

This case is particularly important because it highlights a diagnostic blind spot. For decades, craniopharyngiomas were thought to be tumors that stayed in one place, rarely spreading through the spinal fluid. While a few isolated cases of spinal spread have been reported before, this is the first time the diagnosis was made primarily through the analysis of spinal fluid cells rather than by removing a tumor from the spine first. The doctors in this report emphasize that the initial infection-like symptoms were likely a red herring, possibly caused by the body's own inflammatory response to the tumor, which made the situation look like an abscess. By relying on modern genetic testing and careful cell analysis, the team was able to bypass the confusion of infection and apply a precise treatment that saved the patient from further invasive procedures. It serves as a reminder that when standard treatments for infection fail, the answer might lie in looking for a different kind of cellular traveler entirely.